PARP, poly (ADP-ribose) polymerase; FADD, Fas-associated death domain; TNF, Tumor necrosis factor; TRAIL, TNF-related apoptosis-inducing ligand; cdk, cyclin dependent kinase; cdkI, cdk inhibitor; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; PI, Propidium iodide; cdc2, Cell division cycle 2 kinase. 
Introduction
Prostate cancer (CaP) is the second most prevelant malignancy and the second leading cause of cancer-related deaths among men in the United States with similar trend in many western countries (1) .
Clinically, Cap is usually diagnosed in men over 50 years of age; with increasing life expectancy the incidence of CaP is likely to increase worldwide (1) (2) . Thus, there is a promising opportunity for its intervention using cancer chempopreventive compounds that can prevent or slow the progression of this disease (3) (4) . For a variety of reasons naturally occurring botanicals and dietary substances are gaining increasing attention as cancer chemopreventive agents. Important for CaP chemproprevention is the fact that in recent years, the use of dietary substances and botanical products is showing sustained increase by CaP patients. In CaP a fine balance between cell proliferation and apoptotic death is lost which contributes to increase cellular mass and tumor progression. In this regard, for CaP chemoprevention at the present time there is considerable emphasis in identifying novel botanicals that selectivlely induces apoptosis and growth arrest of CaP cells without producing cytotoxic effects on normal cells.
The rhizome of Kaempferia pandurata Roxb. (Zingiberaceae), a herb cultivated in some tropical countries including Indonesia and Thailand, has been used as a condiment and folk medicine for treatment of various ailments, including colic disorder, fungal infections, dry cough, rheumatism, and muscular pains (5) (6) . Since chalcones are natural products which have been reported to possess a variety of biological properties, including anti-inflammatory, analgesic and antioxidant activities (7) . We recently isolated panduratin A (Fig. 1) , a cyclohexenyl chalcone derivative, from the methanolic extract of K.
pandurata.and reported that it exhibits strong COX-2 inhibitory activity in mouse peritoneal macrophages (8) and induces apoptosis in human colon cancer HT-29 cells (9) . In the present study, we demonstrate antiproliferative and proapoptotic effect of panduratin A in human androgen-independent CaP cells PC3 and DU145 and delineate the mechanism of this effect. 
Materials and Methods

Plant material and chemicals
Anti-caspases, anti-FADD, anti-Fas, anti-FasL, anti-TRAIL, anti-Bid and anti-p27 Kip1 antibodies were procured from Santa Cruze Biotechnology, Inc (Santa Cruze, CA, USA). Anti-cyclins, anti-Bcl-2,
anti-Bax, anti-cdc2, anti-p-cdc2, anti-cdc25C and anti-p21 WAF1/Cip1 antibodies were procured from Cell
Signaling Technology (Beverly, MA, USA). Anti-PAPR 116 and anti-cdk2 antibodies were procured from Upstate Biotechnology (Lake Placid, NY, USA). Anti-PARP p85 antibody was procured from Promega (Madison, WI, USA). Anti-cdk4 and anti-cdk6 antibodies were procured from Biosource International Inc.
(Camarillo, CA, USA). The active compound identified as panduratin A was isolated from the methanolic extract of Kaempferia pandurata (Zingiberaceae) as described earlier (8) . Panduratin A ( 
MTT assay for cellular viability
Cell viability was determined using the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; Sigma Co., USA) assay (11) . The cells were plated at 1 x 10 4 cells per well 200 mL of complete culture medium and treated with designed concentrations of pandurarin A in 96 well microtiter plates for 24 h. Each concentration of panduratin A was repeated in 10 wells. After incubation for specified times at 37 ºC in a humidified incubator, MTT reagent (50 µL, 2 mg/mL in PBS) was added to each well and incubated for 2 h. The microtiter plate containing the cells was centrifuged at 1,800 rpm for 5 min at 4 ºC.
The MTT solution was removed from the wells by aspiration and the formazan crystals were dissolved in DMSO (150 µL). Absorbance was recorded on a microplate reader at 570 nm wavelength. The effect of panduratin A on growth inhibition was assessed as the percentage of inhibition in cell growth where vehicle-treated cells were taken as 100% viable. IC 50 values were determined from three independent experiments.
Apoptosis assessment by annexin-V/Propidium iodide staining
The annexin-V-Fluos staining kit was used for the detection of apoptotic and necrotic cells according to vendor's protocol. This kit uses a dual-staining protocol in which the apoptotic cells are stained with annexin-V (green fluorescence), and the necrotic cells are stained with propidium iodide (red fluorescence). Cells were grown to about 70% confluency and treated with panduratin A (2.5, 5, 10 and 20 µM concentrations) for 24 h. The fluorescence was measured by a Zeiss 410 confocal microscope (Thornwood, NY). Confocal images of green annexin-FITC fluorescence were collected using 488 nm excitation light form an argon/krypton laser, a 560 nm dichroic mirror, and a 514 to 540 nm bandpass barrier filter. Images of red propidium iodide fluorescence were collected using a 568 nm excitation light form the argon/krypton laser, a 560 nm dichroic mirror, and a 590 nm-long pass filter. Densitometric measurement of the bands in western blot analysis were done using digitalized scientific software program UN-SCAN-IT purchased from Silk Science Corporation (Orem, UT, USA).
Reverse -transcription PCR (RT-PCR)
Total RNA was isolated from the cells using a commercial RNeasy kit (Qiagen, Valencia, CA), and RNA concentration was measured spectrophotometrically at 260 nm. Total RNA (1 µg) was subjected to
RT-PCR using one-step RT-PCR premix kit (Promega, Madison, WI) containing all components required to synthesize cDNA and to perform the PCR reaction, and specific primers for p27 kip1 and GAPDH as a 
Statistical analysis
Each experiment was performed at least three times. Results are expressed as the means value ± standard deviation (SD). Statistical analysis was performed using Student's t-test and statistical significance is expressed as * p < 0.05, ** p<0.01.
Results
Inhibition of PC3 and DU145 cell growth by panduratin A
The effect of panduratin A on cell viability was determined employing a MTT assay. As shown in Fig. 2, panduratin A treatment to PrEC ( Fig. 2A) (Fig. 3B ). Taken together, these data indicate that panduratin A-induced cell death is due to the induction of apoptosis in both cell types.
Effect of panduratin A on the expression of apoptosis-related procaspases in PC3 and DU145 cells
Caspases are responsible for many of the biochemical and morphological changes that occur during apoptosis. In next series of experiments, we determined whether treatment of PC3 and DU145 cells to panduratin A leads to activation of caspase. Immunoblot analaysis depicted in Fig. 4 indicates that panduratin A treatment to both cell types led to activation of initiator caspase-9 and caspase-8 as well as procaspase-6 and procaspase-3.
Panduratin A modulates Bcl-2 family proteins in PC3 and DU145 cells
In next series of experiments, we determined the effect of panduratin A treatment to PC3 and DU145 cells on levels of proteins of the Bcl-2 family members. The immunoblot anaysis data showed that the expression of Bax (proapoptosis protein) was significantly increased dose-dependently and time-dependently after treatment of panduratin A in both cell (Fig 5) , wherease the expression of Bcl-2 (antiapoptosis protein) was significantly decreased in a dose-dependent and a time-dependent manner.
Thus, panduratin A treatment was found to result in alteration in Bax/:Bcl-2 ratio in favor of apoptosis that was almost 6-fold higher (at 20 µM) in PC-3 cells and almost 15-fold higher (at 20 µM) in DU145 cells, compared to their respective controls (Fig. 5 ). The levels of native Bid were also significantly decreased dose-dependently in panduratin A treated cell.
Panduratin A induces Fas death receptor-mediated apoptosis in PC3 and DU145 cells
Because panduatin A induced the cleavage of initiator caspase-8, we considered that its proapoptotic response, at least in part, may be mediated via the death receptor-signaling pathway. As shown in Fig 6, in panduratin A treated PC3 and DU145 cells, a significant increase in the expression of FADD protein was observed. Panduratin A treatment was found to cause a dose-dependent up-regulation of the Fas receptor protein without a significant change in the expression of Fas-L in both cells. In addition, a significant change in the expression of TRAIL was also observed in both cell lines (Fig. 6 ). These data suggest that panduratin A treatment also induces apoptosis through extrinsic pathway involving the death receptors.
Panduratin A treatment caused G2/M phase arrest in PC3 and DU145 cells
To investigate whether panduratin A treatment has an effect on the cell cycle regulation, we determined its effect on cell cycle distribution by flow cytometry after staining with PI. As shown in Fig. 7 7B) . Interestingly, the increase in cell population in G1 phase was observed at a concentration of 2.5 µM panduratin A treament in both the cells.
Effect of panduratin A on the expression of cell cycle regulators in PC3 and DU145 cells
Since panduratin A was observed to cause an arrest of cells in G2/M phase, we next assessed its effect on G2/M cell cycle regulators including cdc25C, p-cdc2, cdc2 and cyclin B1. As shown by immunoblot analysis in Fig. 8A , panduratin A treatment of cells caused a dose-dependent decrease in the levels of cdc25C, cdc2 and cyclin B1 proteins. However, the phosphorylation of cdc2 was found to be decreased only in PC3 and not in DU145 cells treated with panduratin A (Fig. 8A) . Next, we assessed the effect of panduarin A on the expression of cyclin D1, cyclin E and cdk2, cdk4 and cdk6. As shown in Fig. 8B , the expression level of cyclin D1 and cyclin E1 significantly decreased following panduratin A treatment in both cell types. We also observed a decreased in the expression of cdk2, cdk4 and cdk6 by panduratin A treatment in both cell lines.
Effect of panduratin A on p27
Kip1 and p21 WAF1/Cip1 in PC3 and DU145 cells
Association of cyclin with cdk forms active kinase complexes, which are regulated and inhibited by binding with cdkI. We next determined the effect of panduratin A treatment of cells on the cytoplasmic levels of p27 Kip1 and p21
. As shown by immunoblot analysis in Fig. 8C , the expression level of p27 Kip1 was increased in a dose-dependent manner by panduratin A treatment in both cell lines. We also determined the effect of panduratin A treatment of cells. Similar to p27 Kip1 protein expression, RT-PCR analysis indicated that expressed p27 Kip1 mRNA was increased in a time-dependent manner by panduratin A treatment in both cell lines (Fig. 9 ). These data show the possibility for the involvement of p27 Kip1 in panduratin A-induced G1 or G2/M phase arrest in both cell lines.
Discussion
CaP is a common malignancy and is the second leading cause of cancer-related deaths of males in the United States with similar trend in many western countries. Because CaP usually occurs in men aged 50
years and older and because of increasing life expectancy, its incidence is exprected to further rise in years to come (12) . CaP usually progresses from androgen-dependent to androgen-independent stage, making antiandrogen therapy ineffective leading to an increase in metastatic potential and incurable malignancy (1-2). Recently, chemoprevention and intervention strategies using anticancer agents are suggested as promising alternative options. The search for new chemopreventive and/or chemoterapheutic agents that are more effective without toxic effects has generated great interest in identifying phytochemicals for their potential use for humans (3) (4) (13) (14) .
Suppression of tumorigenesis often involve modulation of signal transduction pathways, leading to alterations in gene expression, arrest in cell cycle progression or apoptosis. Apoptosis represents a universal and exquisitely efficient suicide pathway, consider as an ideal way for elimination of damaged cells (15) . Recently, the apoptosis signaling systems have been shown to provide promising targets for the development of novel anticancer agents (16) . Several plant-derived bioactive agents are known to be chemopreventive agents by inducing apoptosis in a number of experimental models of carcinogenesis (17) (18) (19) . Thus induction of apoptosis is considered as a possible mechanism of chemopreventive agents.
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